Left ventricular (LV) filling and thus diastolic function are frequently monitored and managed in critical care 1 . While LV systolic function has been extensively studied, there are scant data regarding the diagnosis and prevalence of abnormal diastolic function (diastolic dysfunction) in intensive care unit (ICU) patients. In part, this appears to relate to the challenges of defining and evaluating LV diastolic function in critically ill patients 2 . The bedside application of non-invasive technologies, such as echocardiography (including tissue Doppler) 3 , promise to improve understanding of LV diastolic function in critically ill patients 4 .
Along with improved non-invasive evaluation of LV diastolic function, there is increasing evidence of an association between diastolic dysfunction and elevated plasma b-type natriuretic peptide concentration (BNP) [4] [5] [6] . The present study aimed to evaluate BNP as a marker of diastolic dysfunction in a cohort of 'non-cardiac' ICU patients.
METHODS
This study was conducted at the Royal Brisbane and Women's Hospital. The multidisciplinary, 30bed, tertiary-level ICU admits a broad mix of adult medical and surgical patients, except cardiology (coronary care unit), cardiac surgery and solid organ transplant patients. Therefore enrolled patients were regarded as non-cardiac. 
SUMMARy
Left ventricular filling and thus diastolic function are frequently monitored and managed in critical care. However, scant data exist regarding possible screening tests for diastolic dysfunction in the intensive care unit (ICU). The present study aimed to evaluate plasma b-type natriuretic peptide (BNP) as a marker of diastolic dysfunction in a single-centre cohort of 'non-cardiac' ICU patients. The ICU is non-cardiac in that it provides mixed medical/surgical services with the exception of cardiology, cardiac surgery and solid organ transplantation.
Clinical data were recorded over the first 24 hours of ICU stay for 32 consecutive patients. Transthoracic echocardiogram and blood collection for BNP assay were then performed. Diastolic dysfunction was demonstrated in 34% (n=11). Mean ± standard deviation BNP values were higher with diastolic dysfunction (238±195 vs 72±78 pg/ml; P=0.003). A BNP threshold of >43 pg/ml yielded a sensitivity of 80% and a specificity of 59%; area under the receiver operating characteristic curve was 0.82. BNP correlated independently with E/e' (R=0.425; P=0.015) (E/e': peak early transmitral velocity [E]/early diastolic mitral annular velocity [e']) but not left ventricular ejection fraction (P=0.8), illness severity (Acute Physiological and Chronic Health Evaluation II; P=0.3) or fluid balance (P=0.4).
Diastolic dysfunction was common in this cohort of non-cardiac ICU patients and was independently associated with a significantly higher BNP. The potential application as a screening test for diastolic dysfunction is likely to require a threshold lower than previously proposed for heart failure. QRBW/192) 7 . Informed consent was obtained from each patient or their legally authorised representative.
Patients
A convenience sample of 32 consecutive patients was studied during a one-month period. Nonpregnant adult patients (≥18 years) admitted to the ICU were considered for enrolment if expected ICU length-of-stay exceeded 24 hours. As renal dysfunction may confound the interpretation of BNP 8 , patients with baseline serum creatinine ≥120 μmol/l or with a history of chronic kidney disease, haemodialysis or peritoneal dialysis were excluded. Clinical and demographic data were recorded over the first 24 hours of ICU admission.
Echocardiography
Echocardiography was performed by a single experienced clinician using commercially available equipment (Philips IE33, Philips Healthcare, North Ryde, NSW) on the day following ICU admission. To facilitate blinding, coded measurements were performed offline four months later using Access Point 2000 software (Freeland Systems, Westfield, IN, USA).
LV volumes were measured using the biplane method of disks (modified Simpson's rule) from the apical four chamber and two chamber views. LV ejection fraction (LVEF) <55% was considered indicative of systolic dysfunction 9 . Where indicated, measurements were indexed to body surface area 10 .
Transmitral flow velocities were measured with the sample volume taken at the mitral valve tip in the apical four chamber view 11 . Measurements included diastolic peak passive (E) and active (A) velocities and E wave deceleration time (DT). The apical five chamber view was used to guide measurements of LV outflow tract velocity.
Tissue Doppler measurements were acquired with the pulsed-wave Doppler sample volume placed at both the septal and lateral mitral annulus in the apical four chamber view. Peak velocities were measured during systole (s'), early diastole (e') and late/active diastole (a'). The reported values represent the mean of septal and lateral mitral annulus measurements.
In the presence of atrial dysrhythmia, velocities were calculated as the mean of five consecutive cardiac cycles 12 . If A and/or a' were indistinguishable due to sinus tachycardia, E and/or e' were measured as described by Nagueh and colleagues 13 .
Diastolic dysfunction
LV diastolic function was graded as normal, impaired relaxation, pseudonormal or restrictive 
Biochemical assay
Blood samples collected at the time of echocardiography were centrifuged and stored at -55°C pending batched analysis. Plasma BNP was measured using Advia Centaur ® CP Immunoassay System (Siemens Healthcare Diagnostics Inc, Deerfield, IL, USA) which is a fully automated two-site sandwich immunoassay using direct chemiluminescent technology. Sensitivity and assay range was 2 to 5000 pg/ml.
Statistics
Statistical analysis was conducted using PASW Statistics 18 (SPSS Inc, Chicago, IL, USA). Values are reported as mean ± standard deviation for normally distributed continuous variables. Median, interquartile range and range are reported for variables where the normality assumption was rejected on visual inspection of a normal quantilequantile plot. Number and percentages are reported for categorical variables.
Associations between categorical variables were tested using Pearson's chi-square test or Fisher's exact test as appropriate. A Mann-Whitney U test was used to determine differences in BNP between patient subgroups. A two-tailed P value <0.05 was considered statistically significant.
The ability of BNP to discriminate diastolic dysfunction from normal diastolic function was evaluated. Receiver operator characteristic (ROC) curve analysis was performed. Selection of optimal threshold was based on youden's index. Calculations included sensitivity, specificity, positive predictive value and negative predictive value.
Multiple linear regression was used to determine the association of various variables with BNP. Based upon previously published data 4 , variables included in the model were noradrenaline requirement in the first 24 hours of admission, Acute Physiological and Chronic Health Evaluation (APACHE) II score, LV diastolic dysfunction, LV systolic dysfunction, 24-hour fluid balance and E/e'. Non-normal continuous variables (BNP and E/e' ratio) were log-transformed prior to entry into the model. Stepwise backward elimination of variables with a probability of F >0.10 were removed from the model. Variables in the final model with a P value <0.05 were considered statistically significant.
RESULTS
Thirty-two consecutive patients were studied (Table 1) . Three patients developed a serum creatinine >120 μmol/l after enrolment but before the European Association of Echocardiography/ American Society of Echocardiography recommendations were followed in grading systolic 9 and diastolic function 3 . LVEF=left ventricular ejection fraction. Table 2 .
Diastolic dysfunction was present in 34% (n=11) of the cohort. BNP was higher in the patients with diastolic dysfunction (238±195 vs 72±78 pg/ml; P=0.003). BNP did not reflect systolic dysfunction (LVEF <55%, 87±116 vs 155±165 pg/ml; P=0.3). Table 3 reports categorisation of systolic and diastolic function.
ROC curve analysis was performed to evaluate BNP as a test for diastolic dysfunction (Figure 1) . Area under the ROC curve was 0.82. Guided by youden's index, a BNP threshold of >43 pg/ml offered a sensitivity of 80% and a specificity of 59%. In comparison the more conventional threshold of >100 pg/ml 14 only offered a sensitivity of 60% and a specificity of 27%.
Plasma BNP concentration correlated with E/e' (R=0.425; P=0.015) but not LVEF (P=0.8), APACHE II score (P=0.3) or fluid balance (P=0.4). Multiple linear regression analysis incorporating noradrenaline requirement, APACHE II score, LV diastolic dysfunction, LV systolic dysfunction, fluid balance and E/e' yielded diastolic dysfunction as the only independent predictor of plasma BNP concentration (standardised beta=0.491, P=0.005; adjusted R 2 for the model=0.215).
DISCUSSION
The key finding of this study is a significant relationship between LV diastolic dysfunction and elevated plasma BNP concentration in non-cardiac critical care patients. The hallmark of diastolic dysfunction (pseudonormal or restrictive patterns) is elevated LV filling pressure 3 . Accepting that BNP is primarily secreted by the myocardium in response to ventricular stretch or strain 8 , this is an expected finding reinforced by the observed correlation between BNP and E/e' (a non-invasive estimate of LV filling pressure) 15 .
BNP has been endorsed as a potential marker for heart failure 14 . Clinicians generally accept that BNP reflects systolic dysfunction. However, there is growing evidence of a relationship between diastolic dysfunction and plasma BNP concentration [4] [5] [6] 16 .
BNP is renally excreted and has been found to be raised in patients with renal failure 17 . Thus we intended to exclude patients with pre-existing renal dysfunction. However, even in the absence of renal dysfunction, interpretation of BNP in ICU patients remains difficult due to a multitude of potential confounders. These include, but are not limited to, sepsis, inflammation and myocardial dysfunction 8 , as well as therapies such as intravenous fluid loading 18 .
We found that BNP did not necessarily reflect LV systolic dysfunction. This contrasts with previous data 19 . However, we have previously demonstrated that BNP assay in ICU patients is potentially more reflective of diastolic than systolic dysfunction 4 , in keeping with secretion in response to myocardial stretch. Also, our demonstration of an association between plasma BNP concentration and E/e' (a non-invasive estimate of LV filling pressure) is supported by previous data 6, 20 . Although the reason for lack of association between BNP and systolic dysfunction is not discernible from the present data, it is possible that manipulation of cardiac loading conditions, as commonly occurs in critical care, might be a significant contributor.
Diastolic dysfunction was common (34%), even in this non-cardiac cohort. A BNP cut-off of 43 pg/ ml offered a sensitivity of 80% and a specificity of 59% for diagnosing diastolic dysfunction. The clinical relevance of this requires further evaluation, but BNP might prove acceptably sensitive for diastolic dysfunction screening in the ICU. The lack of specificity reflects the wide range of potential confounders in critically ill patients. The optimal threshold of BNP for excluding diastolic dysfunction is notably lower than that proposed for excluding heart failure (100 pg/ml) 14 . This further emphasises the need for caution in interpreting plasma BNP concentrations in critically ill patients.
The proportion of patients with pre-existing diastolic dysfunction cannot be known due to the inability to reliably predict ICU admission prior to the onset of illness. For reference, recent data from a large population-based cohort (mean age 61±9.5 years; current study 53±18) documents a 23.8% prevalence of LV diastolic dysfunction 21 .
CONCLUSIONS
Diastolic dysfunction was common in this cohort of non-cardiac ICU patients and was independently associated with a significantly higher BNP. The potential application as a screening test for diastolic dysfunction is likely to require a threshold lower than previously proposed for heart failure in other settings.
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